Orlistat is used to treat obesity (Weight loss) along with a reduced calorie and lower-fat diet in adults (18 years and above).
Orlistat: Anti-obesity drugs
Orlistat works by attaching to the enzymes in your digestive system (lipases) and preventing them from breaking down some of the fat that you’ve consumed during your meal. The fat that is not digested cannot be absorbed and it is removed by your body.
Consult your doctor if you experience:
For people who are overweight or obese, the medication Alli is often used for weight management.Some overweight people who are obese also take Orlistat, a prescription weight loss aid. The prescription strength is also low, but this is important to note that it is a medication for weight management purposes. For the most part, the prescription strength is very low, meaning that it is possible to obtain a weight loss solution from a prescription.
Orlistat is a prescription-only weight loss aid that works by blocking fat absorption in the gut. If you're taking Orlistat as a medication, it's essential to make sure that you are taking it as directed. It's important to note that Orlistat is not a magic pill.
If you take Orlistat, you are likely to experience unpleasant side effects that you may not expect. Some side effects that you may not experience include, but are not limited to, oily spotting or oily spotting on your underwear, or oily, fatty, oily patches in your underwear.
The main active ingredient in Orlistat is Orlistat, which blocks the absorption of fat in the body. In general, it's taken by mouth with or without food. Orlistat can also be taken with a meal to help you absorb the fat you have.
You can take Orlistat at a lower dose if it is necessary to, but it is important to be aware of the possible side effects.
If you experience side effects after taking the medication, it is important to speak with your doctor or pharmacist to understand how this medication is working for you.
Orlistat is a medication that can be used to help people who are overweight or obese. If you're taking the prescription strength of Orlistat, it is essential to ensure that you are taking it as directed.
If you are overweight or obese, your doctor may prescribe you Orlistat to help reduce your weight. Orlistat works by blocking the absorption of fat in the body.It is important to take the medication as directed by your doctor, but it is also important to be aware that it can cause side effects, such as oily spotting, diarrhea, and stomach upset.
If you experience any side effects, talk to your doctor or pharmacist to see if you are eligible to take Orlistat.
Side effects of Orlistat are similar to those of other weight loss medications. They are generally mild and disappear as your body adjusts to the medication.
However, some side effects may be more likely when taking Orlistat than when taking the prescription strength of the medication.
Common side effects of Orlistat include oily spotting, flatulence, and flatulence with discharge. If you experience any of these symptoms, speak with your doctor immediately.
If you experience any side effects of Orlistat while taking the prescription strength of the medication, it is important to speak with your doctor or pharmacist to be sure that they are safe to use.
However, if you experience any of the following symptoms, stop taking Orlistat and seek medical attention immediately:
These are all very mild side effects of taking Orlistat. However, if you experience more severe side effects, such as more severe symptoms such as a yellowing of your skin or eyes, it is important to stop taking Orlistat and call your doctor right away.
Objective:To evaluate the efficacy of liraglutide, orlistat, and orlistat XR, and/orlistat and/orlistat XR, both combined, as monotherapy in obese patients with an estimated body mass index (BMI) <30 kg/m2 with an estimated fat distribution >50 kg/m2 with a body mass index ≥28 kg/m2. Methods: A prospective, randomized, double-blind study was conducted in 18 obese patients with an estimated body mass index (BMI) ≥30 kg/m2, a body mass index ≥28 kg/m2 and a body mass index ≥28 kg/m2 of weight loss in a 1:1 ratio. The study population consisted of patients with an estimated body mass index of ≥30 kg/m2 with orlistat XR, and/orlistat and/orlistat XR combined (2:1). A total of 100 patients were randomly allocated into the orlistat plus orlistat group and orlistat group. The treatment period was 7 to 14 days. The weight loss was determined by the investigator using a questionnaire. The primary endpoints were changes in BMI and body weight. The secondary endpoints were changes in waist circumference, waist circumferences, weight and waist circumference. Results: In the total population, the change in BMI and waist circumference was significantly increased with orlistat compared to placebo; and in the orlistat-alone group, the change in BMI and waist circumference was significantly decreased. However, orlistat and orlistat XR were not associated with significant changes in body weight. In addition, waist circumference was significantly increased with orlistat compared to placebo, but not with orlistat XR. There was no significant difference in changes in BMI and waist circumference with orlistat. Conclusions: In obese patients with an estimated body mass index of ≥30 kg/m2 with an estimated body mass index of ≥28 kg/m2 and an BMI of ≥28 kg/m2 with a body weight of ≥100 kg/m2, orlistat XR and/orlistat XR combined, as monotherapy, both were safe and well tolerated in obese patients with an estimated body mass index of ≥30 kg/m2 with a body weight of >100 kg/m2. In patients with an estimated body weight >100 kg/m2 with an estimated body weight of ≥100 kg/m2 with a body weight of >300 kg/m2 with a body weight of >300 kg/m2 with a BMI of ≥28 kg/m2 with a body weight of >28 kg/m2, both drugs were well tolerated. Patients taking orlistat XR and orlistat XR combined and orlistat XR should be counseled to consider alternative treatment options for weight loss. Patients should be counseled to discuss the risks and benefits of weight loss with their healthcare provider before considering any weight loss or treatment.
Controlled Trial Number: NCT04382533. Efficacy and safety of combination of liraglutide, orlistat, and/orlistat XR in obese patients with an estimated body mass index of ≥30 kg/m2 with orlistat XR. Results: A total of 100 patients were randomly allocated into the orlistat plus orlistat group and orlistat group, respectively. The mean BMI of the patients in the orlistat-alone group was 29.7 kg/m2 (22.3-33.6) and the BMI of the patients in the orlistat group was 35.1 kg/m2 (24.8-39.6). There was no significant difference in BMI between the patients in the orlistat plus orlistat group and the patients in the orlistat group.Featured Price: Low to High Price: High to Low Avg. Customer Review Newest ArrivalsSort by
Alli is a top weight-loss brand in Africa,...View MoreAlli is a top weight-loss brand in Africa, offering a range of effective products. With trusted reviews and a commitment to quality, Alli helps individuals achieve their weight-loss goals safely and efficiently.View LessRead More
Alli is a brand of medication that is used for weight loss. It contains the active ingredient Orlistat, which blocks the absorption of fat in the body. Alli is sold over-the-counter and is meant to be used in combination with a low-fat, reduced-calorie diet and exercise program.
- Alli was launched in 2007 by GlaxoSmithKline.
- It was the first FDA-approved over-the-counter weight loss medication.
- In 2014, ownership of the brand was transferred to the British company Reckitt Benckiser.
- Alli is currently available in the United States, the United Kingdom, and Australia.
Xenical is a prescription weight loss medication that also contains Orlistat as its active ingredient. It is marketed by Roche Pharmaceuticals and is available in many countries around the world.
PhenQ is a weight loss supplement that contains a blend of natural ingredients. It is marketed by a company called Wolfson Berg Limited and is available for purchase online.
Hydroxycut is a brand of weight loss supplements that are marketed by Iovate Health Sciences International. The brand offers a variety of products that contain different active ingredients, such as caffeine and green coffee extract.
Alli Capsules are the brand's flagship product. Each capsule contains 60mg of Orlistat and is meant to be taken with meals that contain fat.
Alli is used for weight loss. It works by blocking the absorption of fat in the body.
Alli is meant to be taken with meals that contain fat. You should also follow a low-fat, reduced-calorie diet and exercise program while taking this medication.
Alli is generally considered safe when used as directed. However, it can cause some side effects, such as diarrhea and abdominal pain.
Studies have shown that people who take Alli in combination with a diet and exercise program can lose up to 5% of their body weight within six months.
No, Alli is not recommended for use during pregnancy or breastfeeding.
Copyright © 2025 Ubuy Co. All rights reserved.
ExpertGuidelines to watch out for, Alli recommendationsThe risk of weight gain is a possibility for many individuals taking Alli. While some may experience a temporary gain in weight after a few months, it is not significant.
The chance of developing a weight gain is approximately 0.5% per month, or 0-5 weight intakes. The chance increases to 0.8% if the medication is continued beyond six months.
Studies have shown that those who take Alli in combination with a diet and exercise program have a greater risk of developing a weight gain compared to those who do not.
It is unknown if using Alli is safe or effective for the majority of those who have been shown to.
Stade de France Pharmacy